S&D - I've mentioned this a few times previously, but in early September, as a part of their promo for the partnership conference; in their description of the indications for which the company is pursuing treatments, for MS they emphatically stated, with no qualifiers, " induces remyelination " - and then it was quickly removed. It was as clear as stating " restores homeostasis ".
It's going to be interesting to see what the WSU presentation yields.
News 
Market Data 
Discover 
